Longitudinal Validation of the Artificial Intelligence Algorithm in Home OCT for Age-Related Macular Degeneration-Report 3.

Theodore Leng¹, Ella H Leung², S Krishna Mukkamala², Mehran R Taban³, Moshe Havilio⁴, Kester Nahen⁴, Nishant Mohan⁴, Gidi Benyamini⁴, Tiarnan D L Keenan⁵

¹Byers Eye Institute at Stanford, Stanford University School of Medicine, Palo Alto, California.

²Georgia Retina, Atlanta, Georgia.

³Macula Retina Vitreous Research Institute, Torrance, California.

⁴Notal Vision Inc., Manassas, Virginia.

⁵Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.

PubMed PMC DOI PDF

Abstract

PURPOSE: Longitudinal validation of the artificial intelligence-based Notal OCT Analyzer (NOA) for identification of clinically significant changes in the trajectories of retinal total hypo-reflective volume (TRO) from daily home OCT (HOCT) self-imaging in eyes with age-related macular degeneration. DESIGN: Post hoc analysis of the HOCT Fluid Visualization Agreement Study. PARTICIPANTS: Three hu…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.